Market Place
Sourcing Support
All News #Library
Rare Diseases
Jazz Pharma To Showcase Epidiolex And Xywav At 2026 AAN Annual
09 Apr 2026 //
PR NEWSWIRE
Jazz Pharma Spotlights Epidiolex for Refractory Epilepsy at AES
05 Dec 2025 //
PR NEWSWIRE
Jazz Pharma Reveals Modeyso Data In H3 K27M-Mutant Diffuse Glioma
11 Nov 2025 //
PR NEWSWIRE
Modeyso in NCCN Guidelines for H3 K27M-mutant Diffuse Glioma
09 Sep 2025 //
PR NEWSWIRE
Onco360 Adds Modeyso to Oncology, Rare Cancer Therapy Line
13 Aug 2025 //
GLOBENEWSWIRE
FDA Approves Jazz Pharma`s Drug for Rare Brain Tumor
07 Aug 2025 //
REUTERS
Jazz Pharma Gets EU Approval for Ziihera® in HER2-Positive Cancer
01 Jul 2025 //
PR NEWSWIRE
Jazz gets CHMP nod for Zanidatamab in HER2+ Biliary Tract Cancer
25 Apr 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals Highlights ASCO 2025 Data on Cancer Advances
23 Apr 2025 //
PR NEWSWIRE
Jazz Pharmaceuticals Completes Acquisition of Chimerix
21 Apr 2025 //
PR NEWSWIRE
Horizon, Jazz, Zogenix are buys at BofA despite threat of copycats
19 Sep 2021 //
SEEKINGALPHA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.